An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.
Some professionals stated the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or prison.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down violative content and prohibited related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.
After moments of entering one community, a seller posted WhatsApp details, where most purchases take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.
Item Details and Costs
Inside these communities, messages show dark colored packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for the messaging service stated it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.
Her team has previously encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly significant medical dangers”.
